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Introduction
Double-strand breaks (DSBs) are often generated in 
genomic DNA upon exposure to ionizing radiation 
(IR) or DNA-damaging agents, such as bleomycin and 
neocarzinostatin. Alternatively, DSBs can occur as a result 
of stalling or collapse of the DNA replication forks. If left 
unrepaired, DSBs have the potential to induce genomic 
instability and promote apoptosis or tumorigenesis. Thus, 
when DSBs are recognized by the cell, DNA repair factors 
access these sites of damage and subsequently activate 
DNA repair mechanisms. Radiation-hypersensitive genetic 
disorders have been studied to clarify the mechanisms 
of such DSB damage-induced cellular responses. ATM-
defective Ataxia-Telangiectasia (A-T) is prominent among 
these disorders, and is related to Nijmegen breakage 
syndrome (NBS), which is recognized as a clinical variant of 
A-T (1). NBS is a recessive genetic disorder characterized 
by immunodeficiency, microcephaly, growth retardation, 
and a high frequency of malignancies (2,3). Cells from 
NBS patients exhibit a highly elevated sensitivity to 
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IR, chromosome instability, and abnormal cell cycle 
checkpoints (2,3). The gene mutated in NBS is NBS1 (NBN/
Nibrin), which has been mapped to chromosome 8q21-24 
and is 50 kb in size with 16 exons (2,3). Two mRNAs, 2.6 
and 4.8 kb long, are expressed from the NBS1 gene by using 
2 distinct polyadenylation signals in the 3'-untranslated 
region (3'-UTR). The NBS1 protein interacts with several 
functional proteins, including ATM, and these interactions 
are indispensable for various DNA damage responses. 
Furthermore, NBS1 is considered to be involved in the 
maintenance of genomic stability and the prevention 
of cancer development. Here, we reviewed the damage 
responses linked to NBS1, including ATM-dependent 
cell cycle checkpoints, DSB repair [mainly homologous 
recombination (HR) repair], and translesion DNA synthesis 
(TLS). We also discuss the relationship of NBS1 to the 
development of cancer.
The multiple functions of NBS1
The NBS1 gene is widely conserved in higher eukaryotes. 
Human NBS1, encoding the 754-amino acid (a.a.) NBS1 
protein, has weak homology to the Saccharomyces cerevisiae 
gene encoding Xrs2 at both the N-terminus and C-terminus, 
and has moderate homology to the Schizosaccharomyces 
pombe gene encoding Nbs1 (4,5). Yeast Xrs2 is a subunit of a 
multiprotein complex, which also contains the scMre11 and 
scRad50 proteins and functions in DNA repair. Similarly, 
human NBS1 is a component of the MRN complex along 
with the MRE11 and RAD50 proteins, and appears to 
be a functional homolog of yeast Xrs2. Orthologs of 
human MRE11 and RAD50 have been identified in many 
eukaryotic organisms, indicating that the functions of 
this complex are fundamental to DNA damage responses. 
Furthermore, orthologs of NBS1 have been identified in 
Arabidopsis thaliana, signifying the importance of NBS1 
function in many species. 
NBS1 contains several functional domains, mainly in 
the N-terminus and the C-terminus (Figure 1). A weak 
(29%) homology to the budding yeast Xrs2 protein was 
initially discovered at the N-terminus. This region of NBS1 
includes a forkhead-associated (FHA) domain (a.a. 20-108) 
and 2 BRCA1 C-terminus (BRCT) domains (BRCT1, a.a. 
111-197; and BRCT2, a.a. 219-327). The FHA and BRCT 
domains are widely conserved in eukaryotic nuclear proteins 
related to various cellular processes such as cell cycle 
checkpoints and DNA repair. The BRCT domain has not 
been identified in budding yeast, but is conserved in fission 
yeast with 18% identity. The FHA domain is believed 
to be an interaction motif that binds to phosphorylated 
regions of specific proteins (6). We previously reported 
an interaction between the NBS1 N-terminal domain and 
the phosphorylated histone H2AX that was responsible for 
recruitment of the MRN complex to the vicinity of DSB 
sites (7). FHA also interacts with tandem SDT motifs in 
MDC1 (mediator of DNA-damage checkpoint 1) when 
they are phosphorylated by casein kinase 2 (CK2) (8,9), 
the CK2-dependent phosphorylation is indispensable 
for this interaction. Ctp1, the fission yeast homolog of 
CtIP, contains similar SDT motifs that are important for 
its interaction with the FHA domain of spNbs1 (10,11). 
Furthermore, Lif1, the fission yeast homolog of XRCC4, 
Figure 1 The structure and protein interactions of human NBS1. NBS1 contains several interaction motifs in the N- and C-termini. The 
N-terminal FHA/BRCT domains interact with MDC1, γ-H2AX, TopBP1, and WRN. The C-terminal motifs are indispensable for binding 
to MRE11, ATM, RAD18, and RNF20. These interactions might be important for the maintenance of genomic stability
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interacts with an FHA domain of Xrs2 through its 
phosphorylated SDT motifs (12). Thus, the FHA domain 
may be important for interactions with DNA damage 
response (DDR) proteins.
 Most of the C-terminal sequence of NBS1 shows no 
homology to any known protein, except for several short 
motifs, which are broadly conserved among mammals. Yeast 
two-hybrid experiments demonstrated that one of these 
motifs at the C-terminus (a.a. 682-693) is indispensable 
for direct binding to MRE11 and is essential for nuclear 
transportation of the MRN complex (13). NBS1 has 
3 potential nuclear localization signals (NLSs) at a.a. 
461-467, 590-594, and 751-754. However, the nuclear 
localization of NBS1 is not affected by the deletion of the 
NLS at position 461-467 or the combined deletion of those 
at positions 590-594 and 751-754, indicating that these 
NLSs may be functionally redundant. Subsequent yeast 
two-hybrid analyses suggested an additional interaction 
between RNF20 (yeast Bre1: E3 ubiquitin ligase for histone 
H2B) and the C-terminus of NBS1 (14). This interaction 
requires a conserved motif in NBS1 (a.a. 704-708) and is 
indispensable for the initial step in HR repair. Recently, 
another conserved C-terminal motif (a.a. 639-669) was 
reported to contribute to the interaction with RAD18 (E3 
ubiquitin ligase for PCNA). Direct binding between NBS1 
and RAD18 was confirmed using recombinant proteins, 
and this physical interaction is proposed to be important for 
the regulation of TLS through RAD18 in response to UV 
irradiation (see section 5) (15).
Several SQ motifs, which are consensus sequences 
for phosphorylation by ATM or ATM and Rad3-related 
(ATR) kinases, are found in the central region of NBS1. 
Specifically, serine residues at positions 278 and 343 are 
phosphorylated by ATM in response to radiation both 
in vitro and in vivo (16-18). These serine residues are 
highly conserved in vertebrates (2), although serine-278 
is substituted with threonine in mouse Nbs1, and no 
phosphorylation sites have been identified in S. cerevisiae 
scXrs2 or in S. pombe spNbs1. However, substitution of 
these phosphorylated sites with alanine residues results in 
the abrogation of the intra-S checkpoint in response to DSB 
damage in mammalian cells, which is also observed in cells 
from NBS patients. These data indicate that the central 
region of NBS1 functions in signal transduction during the 
DNA damage response. Additionally, a physical interaction 
between NBS1 and ATM through a conserved C-terminal 
motif (a.a. 734-754) was reported to be essential for the 
recruitment of ATM to DSB sites and the subsequent 
activation of ATM kinase (19).
Recruitment of MRN to DSB damage sites and 
subsequent ATM activation
 
In order to initiate DNA repair, DSBs must be recognized 
by the cell and allowed to promote the recruitment/
accumulation of several nuclear proteins to the sites 
of damage. The accumulation of these proteins can 
be visualized via immunofluorescence analysis using 
specific antibodies. Many of these accumulations appear 
to require histone H2AX, which forms discrete foci 
early in the response to DSBs and may be the initial 
protein phosphorylated by ATM (20). Histone H2AX 
constitutes approximately 10% of human H2A protein and 
is ubiquitously distributed throughout chromatin. The 
phosphorylated form, γ-H2AX, forms foci and co-localizes 
with other DSB-induced foci of DDR-related proteins, 
such as the MRN complex (21). Neither H2ax-/- mouse 
cells nor siRNA-depleted H2AX human cells showed 
NBS1 focus formation in response to DSB damage (22-24), 
suggesting that the interaction between H2AX and NBS1 
is necessary for NBS1 focus formation. Consistent with 
this notion, a DSB damage-induced physical interaction 
between γ-H2AX and NBS1 through the FHA/BRCT 
domain was demonstrated using immunoprecipitation 
assays with recombinant proteins (7). This interaction 
might be important for formation of MRN foci in response 
to DSBs. The interaction with γ-H2AX is also vital for the 
DSB site accumulation (i.e., focus formation) of other DDR 
proteins containing BRCT domains, which also interact 
with phosphorylated residues. Additionally, H2ax-/- mouse 
cells are unable to form BRCA1, 53BP1, and MDC1 foci 
after exposure to radiation, and these proteins also interact 
physically with γ-H2AX (22,23,25). Furthermore, BRCA1, 
MDC1, and TOPBP1 mutants lacking the BRCT domain 
fail to form foci after exposure to radiation (7,26,27). Thus, 
the interaction of DDR proteins with γ-H2AX through 
the BRCT domain (or FHA/BRCT domain of NBS1) is 
important for the recruitment of these proteins to DSBs, 
which is likely required for DSB repair.
It has also been suggested that a direct interaction 
between MDC1 and the FHA domain of NBS1 is important 
for the γ-H2AX-mediated accumulation of NBS1 to DSB 
sites (8,9). MDC1 was identified as a protein that interacts 
with the MRN complex and rapidly forms nuclear foci 
in response to DSBs (25,27-29). Depletion of MDC1 by 
siRNA disrupted the radiation-induced formation of NBS1 
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foci. It was also found that recombinant MDC1 pulled down 
recombinant NBS1 in vitro, whereas MDC1 containing a 
mutated SDT motif (i.e., the CK2 phosphorylation motif) 
did not. Furthermore, reconstitution with the mutated 
MDC1 to MDC1-deficient cells could not form NBS1 
foci following irradiation, and knockdown of CK2 also 
abolished the formation of radiation-induced NBS1 foci. 
Given that MDC1 accumulates at DSB sites in a γ-H2AX- 
dependent manner, it is possible that the interaction of 
NBS1 with MDC1 at its CK2-phopshorylated SDT motifs 
could facilitate the formation of a NBS1-γ-H2AX complex 
and NBS1 focus formation at DSB sites. However, a 
previous study also showed that γ-H2AX is not required 
for the initial recognition of DSBs by DDR proteins under 
certain conditions (30). γ-H2AX and several DDR proteins, 
including NBS1, 53BP1, and BRCA1, are rapidly (within 
minutes) recruited to DNA damage sites irradiated by laser 
microbeams in H2AX-proficient cells (30-32). Although IR-
induced NBS1 focus formation requires H2AX, H2ax-/- mouse 
cells display a similar rapid recruitment of DDR proteins 
after laser microirradiation; however, their cells show defects 
in focus formation after exposure to radiation (7,22,23,25). 
H2AX- or MDC1-depleted cells show a marked decrease 
in the persistence of NBS1 on DSB sites at later time 
points after laser microirradiation (30). Therefore, it is 
possible that the rapid recruitment of NBS1 to DSB sites 
is H2AX independent and instead might require the DNA-
binding protein MRE11, while the subsequent maintenance 
of NBS1 at DSB sites and resulting focus formation are 
H2AX/MDC1 dependent.
A-T is a rare autosomal-recessive neurological disorder 
associated with progressive cerebellar degeneration, and is a 
multisystem syndrome characterized by immunodeficiency, 
predisposition to cancer, radiosensitivity, insulin-resistant 
diabetes, and premature aging (1). The defective gene 
in A-T was identified in 1995 using a positional cloning 
strategy and was designated ATM (ataxia telangiectasia 
mutated). Because many of the cellular and clinical 
features of A-T and NBS overlap, the products of their 
respective causative genes have been predicted to interact 
functionally. ATM encodes the ATM protein, a protein 
kinase that is activated in response to DSB damage with 
a fundamental role in regulating cell cycle checkpoints 
through phosphorylation of DDR proteins such as p53, 
Chk2, and NBS1. Bakkenist and Kastan (33) showed 
that the generation of DSBs by radiation results in an 
intermolecular modification within ATM dimers that leads 
to their activation via autophosphorylation of serine-1981. 
The intermolecular phosphorylation triggers dimer 
dissociation, and the free monomers then phosphorylate 
several nuclear proteins for the recruitment of DDR 
proteins (1,33). NBS1-defective NBS cells and A-T cells 
show radiation-resistant DNA synthesis (RDS), caused by 
the failure of the intra-S checkpoint and abnormal ATM-
dependent phosphorylation of proteins such as of p53 
and Chk2; thus, activation of ATM via a direct physical 
interaction with NBS1 has been indicated. In support of 
this, a conserved region (a.a. 734-754) in the C-terminus of 
NBS1 was found to precipitate recombinant ATM, and an 
anti-ATM antibody was found to co-precipitate the NBS1 
complex with ATM from extracts of irradiated cells (33). 
Furthermore, a mutated NBS1 containing a truncation 
at this conserved region did not interact with ATM, and 
was unable to restore phosphorylated-ATM foci or ATM-
dependent phosphorylation in NBS cells (19). In addition, 
the interaction did not require DSB ends, although DSB 
ends facilitate the MRN-dependent activation of ATM (34). 
Hence, NBS1, likely the MRN complex could be required 
for the recruitment and activation of ATM in the regulation 
of cell cycle checkpoints in response to DSB damage. 
Given that both A-T and NBS patients show cancer 
predisposition, such checkpoint regulation may contribute 
to the prevention of tumorigenesis.
ATR is a member of the ATM family kinases, and is 
activated in response to DNA damage, particularly that 
resulting from replication stalls (35). A critical interacting 
partner of ATR, the ATRIP protein, mediates the accumulation 
of ATR on damaged chromatin via its interaction with the 
RPA complex, which recognizes and coats ssDNA (36). In 
parallel, TopBP1 is recruited by the Rad9-Rad1-Hus1 (9-1-1) 
checkpoint clamp, which is loaded onto DNA by the RAD17-
replication factor C clamp loader complex (35). These actions 
result in the catalytic activation of ATR through direct binding 
of ATR-ATRIP to the activation domain of TopBP1 (35). 
ATR-deficient Seckel syndrome is reported to have certain 
phenotypes in common with NBS, such as microcephaly and 
abnormal regulation of centrosome replication (35,37). NBS 
patient cells also show significant decreases in the ATR-related 
phosphorylation of proteins such as Chk1 and p53 following 
hydroxyurea treatment, and fail to restart stalled replication 
(38,39). Moreover, we observed that the interaction of TopBP1 
with the N-terminus of NBS1 is important for the recruitment 
of TopBP1 to DNA damage sites, suggesting that NBS1 might 
participate in ATR activation through TopBP1 (40). Abnormal 
regulation of the ATR-dependent restart of stalled replication 
could lead to genomic instability, and further studies might be 
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required to clarify a functional relationship between NBS1 and 
ATR and its contribution to cancer development.
The crucial function of NBS1 in HR repair and its 
relationship to NHEJ 
There are at least 2 pathways by which radiation-induced 
DSBs are rejoined: non-homologous end joining (NHEJ) 
and HR repair (Figure 2). The proteins involved in NHEJ 
(including KU70/80, DNA-PKcs, Artemis, XRCC4, and 
DNA ligase IV) and the proteins involved in HR (including 
RAD51, RAD52, and RAD54) are specific to their individual 
DSB repair pathways, whereas the yeast Xrs2 complex (MRX 
complex) is involved in both pathways (41). Mutations to 
yeast Xrs2 resulted in hypersensitivity to DSB-inducing 
agents caused by insufficient NHEJ and HR activity, as well 
as a deficiency in meiotic recombination (42). In higher 
eukaryotes, NBS1 may function in HR repair rather than 
NHEJ (43,44) (Figure 2). Chicken Nbs1-disrupted DT40 
cells show a dramatic reduction in mitomycin C-induced 
sister chromatid exchange (SCE), as do Rad54 and Rad51 
paralog-deficient chicken cells (44-46). We also observed 
that HR-mediated target integrations at specific loci are 
dramatically reduced in Nbs1-deficient chicken cells, and 
that HR events, quantitated using the SCneo reporter gene 
assay, are reduced approximately 200-fold (44). Human cells 
Figure 2 The function of NBS1 in homologous recombination repair. DNA double-strand breaks (DSBs) are mainly repaired via 2 
pathways: non-homologous end joining (NHEJ) and homologous recombination (HR). NBS1 participates in the HR pathway as an MRN 
complex. Upon DSB generation, the MRN complex is recruited to DSB sites, and NBS1/RNF20-dependent chromatin remodeling 
stimulates the resection of DSB ends [generation of single-strand DNA (ssDNA) ends] by MRN/CtIP and other nucleases. MDC1 and 
nucleolin may also participate in this process. The RPA complex then binds to the ssDNA ends and is subsequently exchanged to RAD51. 
The RAD51/ssDNA complex invades the complementary template DNA, and then, DNA synthesis proceeds until capture of the second 
end. The resulting double Holliday junction is resolved by specific nucleases, and the HR repair is completed
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show similar tendencies. NBS patient cells exhibited lower 
HR activity than NBS1-complemented cells in DRGFP 
or SCneo reporter gene analyses, and an NBS1 mutant, 
truncating MRE11-binding region, did not restore HR 
activity (43). Moreover, mutation of the H2AX/MDC1-
interacting FHA/BRCT domain did not result in recovery 
of HR activity to normal levels (43). However, classical 
NHEJ (c-NHEJ) activity appeared to be normal in both 
Nbs1-deficient DT40 cells and NBS patient cells (43,44). 
These results demonstrate that NBS1, as part of the MRN 
complex, is essential for HR-mediated DNA damage repair 
in vertebrates.
Initiation of the HR pathway requires the resection of 
DSB ends, which creates more than 30 single-stranded 
DNA (ssDNA) tails and subsequently promotes binding 
of the replication protein A (RPA) complex. The exchange 
of DNA-binding RPA complexes for RAD51 promotes 
the later step in HR. Several DNA nucleases (MRE11, 
CtIP, EXO1, and DNA2) are known to participate in 
this resection step (47). Recently, it was reported that 
substitution of the CDK-phosphorylating site (serine-432) 
in NBS1 disrupted both the formation of IR-induced RPA 
foci and the generation of ssDNA (48), although the current 
knowledge regarding the role of NBS1 in this resection 
step is limited. Because MRE11 does not possess an NLS 
motif, NBS1 is essential for the nuclear localization of 
MRE11 as a complex, which allows the MRN complex to 
function as a nuclease at DSB ends. The fission yeast Nbs1 
interacts with Ctp1 (the yeast homolog of CtIP), and this 
interaction seems to be important for the recruitment of 
Ctp1 and its function in DSB resection (10,11). In contrast, 
mammalian CtIP is recruited to DSB sites through its 
interaction with BRCA1, and the role played by NBS1 in 
the recruitment of CtIP to DSB sites in mammalian cells is 
unclear (49). However, the cells of NBS1-defective patients 
show deficient formation of IR-induced RPA foci (39), 
indicating the importance of NBS1 in DSB end resection. 
Recently, we identified RNF20 as a novel NBS1-binding 
partner through yeast two-hybrid analysis (14). The siRNA-
mediated depletion of RNF20 decreased the ubiquitination 
of histone H2B and the subsequent recruitment of SNF2h (a 
chromatin remodeling factor) to DSB sites, which facilitates 
HR repair. In addition, RNF20 depletion repressed BRCA1 
and RAD51 HR-related focus formation and HR activity. 
IR-induced RPA focus formation, which is probably CtIP 
dependent, was also attenuated in RNF20-depleted cells, 
suggesting that NBS1 might participate in the regulation of 
end resection through DSB-induced chromatin remodeling. 
Additionally, we found that the major nucleolar protein, 
nucleolin, forms a complex with γ-H2AX, NBS1, MDC1, 
and RPA in response to DSB damage (50). Nucleolin-
depleted cells abrogate HR-related BRCA1, RAD51, and 
RPA foci formation as well as MDC1-related responses, 
and subsequently reduce HR activity. Hence, NBS1 may 
mediate end resection of DSBs through formation of a 
complex with nucleolin and MDC1. Thus, it appears that 
NBS1 may participate in end resection for HR repair 
through several different interactions.
Because NBS patients frequently show chromosomal 
translocations at TCR loci, which are related to class switch 
recombination (51), a limited role for NBS1 or the MRN 
complex in the NHEJ pathway has been suggested. Yeast 
Xrs2 binds to Lif1 (the yeast homologue of LIG IV) through 
its FHA domain (12). Mutations in the FHA domain of 
Xrs2 decreased NHEJ efficiency in budding yeast, although 
they did not influence HR (12), suggesting that Xrs2 might 
participate in the NHEJ pathway through an interaction 
with Lif1. Recently, an alternative NHEJ (alt-NHEJ) 
pathway has been reported, and has also been termed 
microhomology-mediated end-joining (MMEJ) or single-
strand annealing (SSA) repair. It was hypothesized that cells 
deficient in XRCC4, one of c-NHEJ factors, would use 
the alt-NHEJ pathway for DSB repair; however, depletion 
of MRE11 markedly decreased alt-NHEJ, suggesting a 
role of MRE11, likely the MRN complex in the alt-NHEJ 
pathway (52,53). Although V(D)J recombination uses the 
c-NHEJ pathway to rejoin DNA ends generated by RAGs, 
and a defect in c-NHEJ inhibits the complete rejoining 
of the DNA ends, it is possible that alt-NHEJ could also 
be involved (54). Artemis-deficient cells also showed 
activation of alt-NHEJ in V(D)J recombination, whereas 
depletion of NBS1 reduced rejoining of hairpin coding 
end (54), suggesting that NBS1 (and probably the MRN 
complex) may function in alt-NHEJ. DNA ligase IIIα and 
XRCC1 were also reported to be involved in the alt-NHEJ 
pathway (55). The interaction of DNA ligase IIIα/XRCC1 
with MRN has been confirmed by immunoprecipitation, 
particularly in XRCC4-deficient cells (55). Both yeast two-
hybrid analysis and pull-down assays using recombinant 
proteins indicated that NBS1 interacts directly with ligase 
IIIα through its FHA domain (55). Additionally, the MRN 
complex stimulated DNA ligase IIIα/XRCC1-dependent 
intermolecular ligation in vitro, even for incompatible DNA 
ends, which mimics alt-NHEJ (55). These results suggest 
that NBS1, and likely the MRN complex, could participate 
in the alt-NHEJ pathway. In cancer cells, alt-NHEJ 
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appears to be responsible for chromosomal translocation 
and may contribute to DSB repair; thus, the regulation of 
alt-NHEJ by the MRN complex may be related to cancer 
development.
 
The role of NBS1 in the regulation of TLS and 
maintenance of stalled replication forks
NBS is a radiation hypersensitive disorder, and cells from 
NBS patients have also been reported to show sensitivity 
to several DNA-damaging agents such as mitomycin C 
(MMC) and camptothecin (CPT) (2,3). Recently, we also 
reported that NBS1-deficient human and mouse cells are 
mildly sensitive to UV irradiation; however, these cells 
were not defective in nucleotide excision repair (NER) 
after UV-induced DNA damage (15). DNA damage 
induced by UV, MMC, and CPT can cause stalling 
or collapse of DNA replication forks in S-phase cells. 
Such replication blocks are circumvented by TLS DNA 
polymerases, which can insert nucleotides across DNA 
lesions at replication-blocked sites (56). Eukaryotes 
possess several TLS DNA polymerases, each presumably 
responsible for bypass of a specific lesion or class of lesions. 
Of them, Polη is implicated in the error-free bypass of 
UV-induced cyclobutane pyrimidine dimers (CPD) (57). 
In UV-irradiated human cells, Polη is recruited to DNA 
damage sites, presumably at stalled replication forks, and 
interacts with monoubiquitinated PCNA (58-60). The 
monoubiquitination of PCNA is carried out in a RAD6/
RAD18-dependent manner (61). Thus, the RAD6/RAD18-
dependent monoubiquitination of PCNA is essential for the 
activation of Polη-dependent TLS at UV-induced DNA 
damaged sites. We found that NBS1-deficient mouse and 
human cells could not induce PCNA monoubiquitination 
and had defects in both RAD18 and Polη foci formation 
fol lowing UV irradiat ion (15) .  Furthermore,  we 
characterized the UV-induced interaction between RAD18 
and the essential domain in the C-terminus (a.a. 639-669) 
of NBS1. This interaction appears to be indispensable for 
the recruitment of RAD18 to UV-induced DNA-damaged 
sites and the subsequent monoubiquitination of PCNA, and 
could be related to UV sensitivity. Additionally, a HITEC 
mutation assay revealed that NBS1-deficient mouse cells 
exhibited similar mutation spectra (base transition and 
transversion) to those of Polη-deficient cells. Thus, NBS1 
could function in the activation of the Polη-dependent 
TLS pathway (Figure 3 pathway 1). We also reported an 
additional involvement of NBS1 in Polη-dependent TLS 
(Figure 3 pathway 2). Werner syndrome (WS), an autosomal 
recessive disorder with premature aging and cancer 
predisposition, shows spontaneous RAD18 and Polη focus 
formation and an increase in PCNA monoubiquitination 
in the absence of exogenous DNA damage (62). WS 
patient cells also show an increase in the frequency of supF 
mutations in a RAD18-dependent manner. In normal cells, 
a WRN-PCNA interaction prevents the RAD18-mediated 
monoubiquitination of PCNA; however, PCNA is released 
from WRN via WRN degradation following DNA damage, 
leading to PCNA monoubiquitination and the subsequent 
activation of TLS. In response to DSB, NBS1 interacts 
with WRN through its FHA domain, and this is followed 
by ATM/NBS1-mediated phosphorylation of WRN, 
which seems to trigger WRN degradation. Thus, WRN 
degradation by ATM/NBS1 could be important for the 
regulation of Polη-dependent TLS. TLS DNA polymerases 
such as Polη can be error-prone across normal bases (63). 
Therefore, NBS1 could be important for the maintenance 
of genomic stability and the prevention of tumorigenesis 
through its interactions with RAD18 and WRN (Figure 3). 
The role of NBS1 in the maintenance of normal 
DNA replication has also been reported (38,48). Stalling 
of DNA replication forks induced by UV, MMC, and 
CPT typically allows a normal restart of replication 
after completion of DNA repair at the damaged sites, 
although this process is superseded by the TLS system 
in some situations. However, NBS patient cells cannot 
restart aphidicolin-induced stalled DNA forks after 
washout of aphidicolin (38,48). Falk et al. also reported a 
defect in the restart of aphidicolin-induced stalled DNA 
in MRE11-deficient AT-LD patient cells and NBS cells 
(48,64). NBS1 mutated at the CDK-phosphorylating site 
(serine-432) cannot restore this restart defect in NBS cells; 
therefore, phosphorylation by CDK may be important for 
the restart of stalled replication forks. Failure to restart 
stalled replication forks is likely to generate DSBs requiring 
HR repair. Such unnecessary activation of HR may cause 
tumorigenesis, and thus, the role of NBS1 in the regulation 
of replication fork restart, in addition to its role in TLS 
regulation, could contribute to the prevention of cancer 
development. 
The relationship between NBS1 and cancer 
development 
There is accumulating evidence that ATM-dependent 
checkpoint mechanisms function as an anti-cancer barrier 
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in human tumorigenesis (65,66). When ATM/ATR-
dependent phosphorylation was compared in clinical tumor 
specimens from different stages of human urinary bladder 
cancer, both auto-phosphorylation of ATM and ATM-
dependent phosphorylation of substrates such as Chk2 and 
p53 increased remarkably in the early-stage tumors (65). 
However, these phosphorylations diminished at advanced 
stages, likely because of the inactivation of the ATM-
related pathway. Various tumors show a similar tendency, 
indicating that the ATM-related DNA damage response 
could play an important role as a barrier to the malignant 
progression of tumors. As NBS1 plays a crucial role in 
ATM activation in response to DSBs, NBS1 inactivation 
could disturb the ATM-dependent anti-cancer barrier, 
leading to cancer progression. In fact, NBS patients, whose 
cells show defective activation of ATM, are particularly 
prone to developing malignancies (especially lymphoma 
and leukemia) at a young age (2,3). In the case of a 657del5 
mutation, which is a major NBS1 mutation resulting in 
the translation of 2 truncated hypo-functional proteins (a 
short N-terminal fragment and a C-terminal fragment), 
heterozygous carriers are at an increased risk of several 
types of lymphoma (67). Furthermore, several studies 
showed the presence of a homozygous 657del5 mutation 
in some types of lymphoma and breast cancer from healthy 
subjects; however, the relationship with cancer risks in 
these patients has been controversial (68,69). Homozygous 
mutations of R215W or I171V have also been identified as 
minor mutations in NBS patients. These mutations could 
disturb the BRCT1 domain, possibly leading to typical NBS 
phenotypes. However, several studies have shown that these 
mutations do not increase cancer risk (67).
Because NBS1 is highly polymorphic, with 675 single-
nucleotide polymorphisms (SNPs), the relationship of the 
SNPs to cancer risk has been investigated. In particular, the 
role of the E185Q (rs1805794 C/G) polymorphism in lung 
Figure 3 The function of NBS1 in translesion DNA synthesis. <pathway 1> NBS1 interacts with RAD18 in response to replication stresses 
such as UV irradiation and recruits it to DNA damage sites, leading to PCNA ubiquitination and subsequent TLS activation. <pathway 
2> In the absence of DNA damage, the interaction of WRN with PCNA inhibits PCNA ubiquitination and subsequent TLS activation. 
When replication stress occurs, WRN is phosphorylated by ATM/NBS1 and this phosphorylation leads to the degradation of WRN and 
subsequent release of PCNA. The PCNA is then free to be monoubiquitinated by RAD18/RAD6, leading to TLS. The regulation of TLS 
by NBS1 may function as an anti-cancer barrier
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cancer has been the focus of several studies. These studies 
have shown an association of homozygous E185Q with 
breast cancer in the USA (70), nasopharyngeal carcinoma 
(NC) in China (71), acute lymphoblastic leukemia (ALL) 
in China (72), and lung cancer in China (73). Although 
E185 is in the BRCT1 domain, it is unclear whether the 
E185Q mutation in NBS1 disturbs NBS1-related DNA 
damage responses. However, the introduction of substituted 
NBS1 (E185Q) into CEN-2 cells (human nasopharyngeal 
carcinoma cell line) increased migration significantly, 
compared to the introduction of wild-type NBS1 (71). This 
result suggests that NBS1 may also contribute to cancer 
progression through a mechanism unrelated to its role in 
the DNA damage response. 
Recently, 2 NBS1 SNPs, rs1063054 and rs1063053 in 
the 3'-UTR, were demonstrated to be associated with lung 
cancer in a Los Angeles study and non-Hodgkin lymphoma 
in a South Asian study, respectively (72,74). In addition, 
Yang et al. reported that another SNP (rs2735383) in the 
3'-UTR of NBS1 was related to an increased risk of lung 
cancer in China (75). Homozygotes of rs2735383CC showed 
decreased expression of NBS1 mRNA and protein in lung 
cancer tissues compared to GG or GC genotypes. Yang et 
al. also reported that the rs2735383C allele could interact 
with hsa-miR-629, and introduction of this microRNA 
caused a larger decrease in transcriptional activity of the C 
allele than the G allele (75). This finding suggests that the 
rs2735383G>C substitution could facilitate the interaction 
of hsa-miR-629 with the 3'-UTR of NBS1, leading to 
repression of NBS1 mRNA/protein levels. This reduction 
in NBS1 could cause dysfunction in both the DSB repair 
and cell cycle checkpoint processes, and consequently 
promote lung cancer progression. On the other hand, the 
increased expression of NBS1 seems to contribute to the 
development of several types of cancer, such as non-small 
lung cell cancer and uveal melanoma (67,76). It was also 
reported that the 6-year actuarial survival in aggressive head 
and neck cancer patients was significantly lower in the 
high NBS1 group than in the low NBS1 group (22% vs. 
100%) (77). Given that the up-regulation of NBS1 could 
enhance TLS activity and the spontaneous activation of 
TLS could lead to genomic instability (62,63), an increase 
in NBS1 levels may contribute to cancer development 
through the NBS1/RAD18/Polη-dependent TLS pathway. 
To date, the information regarding an association 
between NBS1 and cancer risk is limited to N-terminal 
mutations or SNPs and the 3'-UTR. However, the NBS1 
protein also has several functional domains in C-terminus; 
thus, further study in this portion of NBS1 will likely be 
required to clarify the role of NBS1 in cancer development. 
Future perspectives
NBS1 is a multifunctional protein with several interaction 
sites for MRE11, ATM, MDC1, RNF20, RAD18, and 
WRN. Through these interactions, NBS1 functions in HR 
repair, ATM-dependent checkpoint processes and TLS, 
and could contribute to maintenance of genomic stability. 
Hence, a relationship of NBS1 to cancer development (or 
cancer risk) has been suggested. Thus far, investigation 
of the link between NBS1 and cancer has been limited to 
SNPs (or deletions and mutations) in the N-terminal FHA/
BRCT domain and the 3'-UTR. However, NBS1 also has 
4 C-terminal interaction motifs involved in HR repair, cell 
cycle checkpoints, and TLS, and the tumor-related effects 
of the SNPs in these motifs remain to be undetermined. 
Therefore, investigations into the relationship between 
C-terminal SNPs (or mutations) and cancer risks will 
be necessary in order to further clarify the role of the 
important genome maintenance factor, NBS1, in cancer 
development.
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